These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 526908)

  • 21. [Rubidazone (22 050 RP): clinical study. Phase II trial in solid tumors and lymphomas (author's transl)].
    Chauvergne J; Cappelaere P; Carton M; Gary-Bobo J; Klein T
    Bull Cancer; 1978; 65(1):19-24. PubMed ID: 667371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
    Kovach JS; Ames MM; Sternad ML; O'Connell MJ
    Cancer Res; 1979 Mar; 39(3):823-8. PubMed ID: 427770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of doxorubicin versus epirubicin in advanced breast cancer.
    Brambilla C; Rossi A; Bonfante V; Ferrari L; Villani F; Crippa F; Bonadonna G
    Cancer Treat Rep; 1986 Feb; 70(2):261-6. PubMed ID: 3456271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Blessing J; Hanjani P; Kramer P;
    Gynecol Oncol; 2005 Mar; 96(3):749-52. PubMed ID: 15721421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer.
    Sledge GW; Robert N; Sparano JA; Cogleigh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):105-8. PubMed ID: 7597425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
    Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
    Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Thigpen JT; Buchsbaum HJ; Mangan C; Blessing JA
    Cancer Treat Rep; 1979 Jan; 63(1):21-7. PubMed ID: 369691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rubidazone in the treatment of recurrent acute leukemia in children. A Pediatric Oncology Group Study.
    Ragab AH; Boyett JM; Frankel L; Falletta J
    Cancer; 1986 Apr; 57(8):1461-3. PubMed ID: 3948126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of rubidazone (NSC 164011) in children with cancer.
    Tan CT; Mitta SK; Steinherz L; Miller DR
    Med Pediatr Oncol; 1981; 9(4):347-53. PubMed ID: 7266427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rubidazone in metastatic breast cancer.
    Legha SS; Benjamin RS; Buzdar AU; Hortobagyi GN; Blumenschein GR
    Cancer Treat Rep; 1979 Jan; 63(1):135-6. PubMed ID: 369685
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo.
    Skovsgaard T
    Cancer Chemother Rep; 1975; 59(2 Pt 1):301-8. PubMed ID: 1149008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay system.
    Alberts DS; Van Daalen Wetters T
    Br J Cancer; 1976 Jul; 34(1):64-8. PubMed ID: 952715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. Breast Cancer Cooperative Group.
    Van Oosterom AT; Mouridsen HT; Wildiers J; Paridaens R; Cocconi G; Rotmensz N; Sylvester R
    Eur J Cancer Clin Oncol; 1986 May; 22(5):601-5. PubMed ID: 3770031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of adriamycin and bleomycin in patients with multiple myeloma.
    Bennett JM; Silber R; Ezdinli E; Levitt M; Oken M; Bakemeier RF; Bailar JC; Carbone PP
    Cancer Treat Rep; 1978 Sep; 62(9):1367-9. PubMed ID: 80275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.
    Smith DB; Howell A
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):391-4. PubMed ID: 3475204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 37. VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group Study.
    Vaughn CB; Green SJ; O'Bryan R; Reed M; Grozea PN; Fletcher WS; Green JB; Metch B; Oishi N
    Med Pediatr Oncol; 1988; 16(5):312-9. PubMed ID: 3054453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
    Rozencweig M; ten Bokkel Huinink W; Cavalli F; Bruntsch U; Dombernowsky P; Høst H; Bramwell V; Renard G; Van Glabbeke M; Decoster G
    J Clin Oncol; 1984 Apr; 2(4):275-81. PubMed ID: 6584561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA
    Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma.
    Decker RA; Elson P; Hogan TF; Citrin DL; Westring DW; Banerjee TK; Gilchrist KW; Horton J
    Surgery; 1991 Dec; 110(6):1006-13. PubMed ID: 1745969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.